Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date29 Apr 2019 |
|
MechanismKATP channels activators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date21 Sep 1983 |
|
MechanismGABA transaminase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date24 May 1974 |
评价食物对盐酸帕洛诺司琼口颊膜药代动力学影响的Ⅰ期临床研究
[Translation] Phase I clinical study to evaluate the effect of food on the pharmacokinetics of palonosetron hydrochloride buccal film
评估食物对健康受试者服用0.5 mg盐酸帕洛诺司琼口颊膜药代动力学的影响。
[Translation] To evaluate the effect of food on the pharmacokinetics of 0.5 mg palonosetron hydrochloride buccal film in healthy subjects.
盐酸帕洛诺司琼口颊膜的安全性、耐受性和相对生物利用度的Ⅰ期试验
[Translation] Phase I trial of safety, tolerability and relative bioavailability of palonosetron hydrochloride buccal film
评估健康受试者在空腹条件下服用0.5 mg盐酸帕洛诺司琼口颊膜的相对生物利用度、安全性和耐受性。
[Translation] To evaluate the relative bioavailability, safety, and tolerability of 0.5 mg of palonosetron hydrochloride buccal film in healthy subjects under fasting conditions.
健康受试者在餐后条件下口服丙戊酸钠缓释片0.5 g受试制剂和参比制剂的生物等效性试验
[Translation] Bioequivalence study of the test and reference preparations of sodium valproate sustained-release tablets 0.5 g in healthy subjects after oral administration
评价健康受试者在餐后条件下单剂量服用厦门力卓药业有限公司研制的丙戊酸钠缓释片0.5 g(受试制剂)与丙戊酸钠缓释片0.5 g(参比制剂)的生物等效性以及安全性
[Translation] To evaluate the bioequivalence and safety of a single dose of valproate sodium sustained-release tablets 0.5 g (test preparation) and valproate sodium sustained-release tablets 0.5 g (reference preparation) developed by Xiamen Lizhuo Pharmaceutical Co., Ltd. in healthy subjects after a meal.
100 Clinical Results associated with Lizhuo Pharmaceutical (Xiamen) Co., Ltd.
0 Patents (Medical) associated with Lizhuo Pharmaceutical (Xiamen) Co., Ltd.
100 Deals associated with Lizhuo Pharmaceutical (Xiamen) Co., Ltd.
100 Translational Medicine associated with Lizhuo Pharmaceutical (Xiamen) Co., Ltd.